Kine Sciences Co., Ltd.
Clinical trials sponsored by Kine Sciences Co., Ltd., explained in plain language.
-
New drug KINE-101 tested for tough nerve disorder
Disease control CompletedThis early-stage study tested a single dose of a new drug called KINE-101 in 9 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) that did not improve with steroids. The main goal was to check safety and side effects over 28 days. Researchers also looked at whet…
Phase: PHASE1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug KINE-101 put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called KINE-101 in 24 healthy adults. Participants received daily infusions of the drug or a placebo for 7 days. The goal was to see if the drug is safe and how the body processes it. No treatment benefit was expected since a…
Phase: PHASE1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:07 UTC
-
New drug KINE-101 tested in healthy people for first time
Knowledge-focused CompletedThis early-stage study tested a new drug called KINE-101 in 40 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single dose through an IV or injection. The study is complete and provides important safety in…
Phase: PHASE1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC